PR Newswire

ABBOTT PARK, Ill., Jan. 20, 2017 /PRNewswire/ -- New research has found spinal cord stimulation (SCS) therapy can be key to reducing or stabilizing the use of opioids in patients battling chronic pain. In a new study, researchers examined opioid usage data from more than 5,400 patients both prior to…

LEAWOOD, Kan., Jan. 20, 2017 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals, won Animal Pharm\'s Best Company in North America 2016. Aratana was granted the award based on the FDA approval of…

BOULDER, Colo., Jan. 20, 2017 /PRNewswire/ -- Bioptix, Inc. (Nasdaq: BIOP) (\"Bioptix\" or the \"Company\"), announced that on January 14, 2017 the Board of Directors of the Company adopted a plan under which the Company will terminate certain employees associated with the September 2016 acquisition of its subsidiary, Bioptix Diagnostics,…

ATLANTA, Jan. 20, 2017 /PRNewswire-USNewswire/ -- A study published today in The New England Journal of Medicine provides compelling evidence that extensively drug-resistant tuberculosis (XDR TB) is spread from person-to-person in the KwaZulu-Natal province, South Africa from 2011–2014. The study was conducted by a team of researchers from Emory University,…

CAMBRIDGE, Mass., Jan. 20, 2017 /PRNewswire/ -- Today, during a plenary session at the Keystone Symposia Conference, \"PI3K Pathways in Immunology, Growth Disorders and Cancer,\" Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) presented preclinical data for IPI-549, an oral immuno-oncology development candidate that selectively inhibits phosphoinositide-3-kinase-gamma (PI3K-gamma). Preclinical data showed that IPI-549 is…

PARSIPPANY, N.J., Jan. 20, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)(\"Interpace\" or the \"Company\"), a company that provides clinically useful molecular diagnostic tests and pathology services, today announced that it has entered into a securities purchase agreement with three  institutional investors to purchase an aggregate of 855,000 shares…

REDWOOD CITY, Calif., Jan. 20, 2017 /PRNewswire/ -- ARMO BioSciences, Inc., a late-stage immuno-oncology company, presented new Phase 1b clinical data on the Company\'s lead investigational immuno-oncology drug AM0010 (PEGylated Interleukin-10) at the 2017 Gastrointestinal Cancers Symposium, co-sponsored by the American Society of Clinical Oncology (ASCO), taking place January 19-21,…

PRINCETON, N.J., Jan. 20, 2017 /PRNewswire-USNewswire/ -- The New Jersey Hospital Association, the state\'s oldest and largest healthcare trade association, today held its annual awards program to honor several individuals and organizations for their commitment to the state\'s healthcare system and the patients and communities they serve. The awards were presented…

PRINCETON, N.J., Jan. 20, 2017 /PRNewswire-USNewswire/ -- Steven G. Littleson, FACHE, of Fair Haven, president of the hospital services division and chief operating officer of Hackensack Meridian Health, today was installed as chairman of the Board of the New Jersey Hospital Association, the state\'s oldest and largest hospital and healthcare advocacy…

VALENCIA, Calif., Jan. 20, 2017 /PRNewswire/ -- Bioness, Inc., the leading provider of state-of-the-art, clinically supported rehabilitation and pain management medical devices, is pleased to announce data surrounding the clinical benefits of its StimRouter Neuromodulation System. At the 2017 North American Neuromodulation Society\'s (NANS) Annual Meeting in Las Vegas, Nevada,…